![1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2S)-2-(5-chloro-2-pyridinyl)-2-methyl-1,3-benzodioxol-4-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- structure, CAS 2401892-75-7](/structures/210000/192994_1_2401892_75_7.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2401892-75-7 |
| Catalog No. | 2A-1191491 |
| Chinese Name | Lotiglipron |
| Molecular Formula | C31H31O5N4Cl1 |
| Molecular Weight | 575.06 |
| Application | Lotiride pron (PF-07081532) is an orally active GLP-1R agonist. Lotiripron can reduce blood sugar and body weight and can be used in research on type 2 diabetes (T2DM) [1]. |
| PubChem ID | 406094172 |
| MDL Number | MFCD35067945 |
| SMILES | CC1(c2ccc(Cl)cn2)Oc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4CC4CCO4)CC3)c2O1 |
| InChI | InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38)/t22-,31-/m0/s1 |
| InChI Key | SVPYZAJTWFQTSM-UGDMGKLASA-N |
| Transport Info | Product name: Compound Lotiglipron |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-3-phenylpyrrolidine | 62624-46-8 | 2A-1191475 |
| (S)-BoroLeu-(-)-Pinanediol-CF3COOH | 477254-69-6 | 2A-1191476 |
| (R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride | 1243174-57-3 | 2A-1191483 |
| 4-Chlorothiazolo[4,5-c]pyridine | 214045-74-6 | 2A-1191488 |
| 2-PHENYL-THIAZOLO[5,4-C]PYRIDINE | 52334-38-0 | 2A-1191490 |
| 4-bromo-3-methoxybenzenesulfonyl chloride(SALTDATA: FREE) | 1215295-91-2 | 2A-1191495 |
| 4-Dimethylcarbamoyl-benzenesulfonyl chloride | 190711-50-3 | 2A-1191498 |
| (1R,6S)-3-Boc-3,8-diazabicyclo[4.2.0]octane | 370882-99-8 | 2A-1191505 |
| tert-butyl 3,8-diazabicyclo[4.2.0]octane-3-carboxylate | 370881-96-2 | 2A-1191507 |
| Benzenamine, 4-[5-(4-morpholinylmethyl)-1H-1,2,4-triazol-3-yl]- | 1263285-13-7 | 2A-1191509 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA